Cell cycle control by cell-matrix interactions
dc.contributor.author | Jones, MJ | |
dc.contributor.author | Jones, MC | |
dc.date.accessioned | 2023-12-18T12:44:30Z | |
dc.date.available | 2023-12-18T12:44:30Z | |
dc.date.issued | 2024-02 | |
dc.identifier.issn | 0955-0674 | |
dc.identifier.issn | 1879-0410 | |
dc.identifier.other | 102288 | |
dc.identifier.uri | https://pearl.plymouth.ac.uk/handle/10026.1/21807 | |
dc.description.abstract |
Cell adhesion to the extracellular matrix (ECM) is required for normal cell cycle progression and accurate cell division. However, how cell adhesion to the wide range of ECM proteins found in human tissues influences the cell cycle is not fully understood. The composition and physical properties of the ECM can have profound effects on cell proliferation but can also promote cell cycle exit and quiescence. Furthermore, during tumor development and progression, changes in the ECM can drive both cancer cell proliferation and dormancy. Cell-matrix adhesion is primarily sensed via integrin-associated adhesion complexes, which in turn are regulated by the cell cycle machinery. In particular, cyclin-dependent kinase 1 (CDK1) has been shown to play a crucial role in regulating adhesion complexes during interphase and entry into mitosis. These reciprocal links between cell cycle progression and cell-matrix interactions are now being identified. | |
dc.format.extent | 102288-102288 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.publisher | Elsevier BV | |
dc.subject | Humans | |
dc.subject | Cell Cycle | |
dc.subject | Cell Cycle Proteins | |
dc.subject | Cell Cycle Checkpoints | |
dc.subject | Cell Proliferation | |
dc.subject | Cell Adhesion | |
dc.subject | Mitosis | |
dc.subject | Neoplasms | |
dc.title | Cell cycle control by cell-matrix interactions | |
dc.type | journal-article | |
dc.type | Article | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/38056140 | |
plymouth.volume | 86 | |
plymouth.publisher-url | http://dx.doi.org/10.1016/j.ceb.2023.102288 | |
plymouth.publication-status | Published | |
plymouth.journal | Current Opinion in Cell Biology | |
dc.identifier.doi | 10.1016/j.ceb.2023.102288 | |
plymouth.organisational-group | |Plymouth | |
plymouth.organisational-group | |Plymouth|Faculty of Health | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|Users by role | |
plymouth.organisational-group | |Plymouth|Users by role|Academics | |
plymouth.organisational-group | |Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine | |
plymouth.organisational-group | |Plymouth|Faculty of Health|Peninsula Medical School | |
plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA | |
plymouth.organisational-group | |Plymouth|REF 2028 Researchers by UoA|UoA01 Clinical Medicine | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2023-11-08 | |
dc.date.updated | 2023-12-18T12:44:30Z | |
dc.identifier.eissn | 1879-0410 | |
dc.rights.embargoperiod | forever | |
rioxxterms.versionofrecord | 10.1016/j.ceb.2023.102288 |